Novo Nordisk A/S (NVO)
NYSE: NVO · IEX Real-Time Price · USD
142.98
-2.44 (-1.68%)
At close: Jul 2, 2024, 4:00 PM
142.96
-0.02 (-0.01%)
After-hours: Jul 2, 2024, 7:58 PM EDT

Novo Nordisk Market Cap

Novo Nordisk has a market cap or net worth of $628.28 billion as of July 2, 2024. Its market cap has increased by 73.23% in one year.

Market Cap
628.28B
Enterprise Value
630.82B
1-Year Change
73.23%
Ranking
Category
Stock Price
$142.98

Market Cap Chart

Since December 31, 2002, Novo Nordisk's market cap has increased from $9.98B to $628.28B, an increase of 6,195.98%. That is a compound annual growth rate of 21.23%.

History

DateMarket Cap% Change
Jul 1, 2024655.84B39.03%
Dec 29, 2023471.73B54.12%
Dec 30, 2022306.08B19.24%
Dec 31, 2021256.69B55.86%
Dec 31, 2020164.70B16.14%
Dec 31, 2019141.81B23.12%
Dec 31, 2018115.18B-15.84%
Dec 29, 2017136.86B46.79%
Dec 30, 201693.24B-38.18%
Dec 31, 2015150.82B29.59%
Dec 31, 2014116.38B12.48%
Dec 31, 2013103.47B9.30%
Dec 31, 201294.66B36.88%
Dec 30, 201169.16B-0.91%
Dec 31, 201069.79B72.41%
Dec 31, 200940.48B26.82%
Dec 31, 200831.92B-22.43%
Dec 31, 200741.15B52.03%
Dec 29, 200627.07B44.82%
Dec 30, 200518.69B1.87%
Dec 31, 200418.35B29.73%
Dec 31, 200314.14B41.73%
Dec 31, 20029.98B-
View and export this data all the way back to 2002. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly 860.48B
UnitedHealth Group 468.72B
Johnson & Johnson 351.76B
Merck & Co. 313.56B
AbbVie 302.88B
AstraZeneca 241.81B
Thermo Fisher 211.09B
Novartis AG 208.29B
Market Cap Rankings